$HZNP Recent News Why this year’s rally is not the

New Post Public Reply Private Reply Replies (0) Message Board

Jul 18, 2014 at 10:35 AM

$HZNP Recent News

Why this year’s rally is not the same as last year’s 2:27 p.m. July 15, 2014 - The Trading Deck
Stocks are poised for a jump higher 12:30 p.m. June 10, 2014 - The Trading Deck
Two health-care names ready to run 12:28 p.m. June 5, 2014 - The Trading Deck
6 stocks to watch 3:13 p.m. June 4, 2014 - The Trading Deck
Charting a bullish second-quarter backdrop 12:34 p.m. April 1, 2014 - Michael Ashbaugh
Charting a bullish second-quarter backdrop 12:20 p.m. April 1, 2014 - Michael Ashbaugh
S&P 500 retests major support 12:47 p.m. March 27, 2014 - Michael Ashbaugh
Thursday’s biggest gaining and declining stocks 4:27 p.m. Sept. 20, 2012 - Greg Morcroft
Horizon Pharma prices offering at steep discount 9:54 a.m. Sept. 20, 2012 - MarketWatch.com
Five companies detail stock offerings 9:39 a.m. Sept. 20, 2012 - MarketWatch.com
Stocks to watch Friday: Goldman, Bally, Scotts 6:54 a.m. Aug. 10, 2012 - MarketWatch
Horizon Pharma down 18% following drug approval 10:59 a.m. July 27, 2012 - Val Brickates Kennedy
Horizon Pharma opens flat post-IPO 12:00 p.m. July 28, 2011 - MarketWatch.com

Biggest Movers in Healthcare Stocks Now – HZNP ARNA GB SGEN 2:15 p.m. July 10, 2014 - InvestorPlace.com
5 Newly Profitable Stocks to Buy – Screen of the Week 6:59 a.m. July 9, 2014 - InvestorPlace.com
A Company's First Profit Can Mean Big Profits to Investors - Screen of the Week 2:11 a.m. July 8, 2014 - Zacks.com
Salix Pharmaceuticals Surges on Positive IBS Data - Analyst Blog 6:15 p.m. July 2, 2014 - Zacks.com
Amgen Gets Breakthrough Therapy Status for Leukemia Drug - Analyst Blog 5:55 p.m. July 2, 2014 - Zacks.com
Hottest Healthcare Stocks Now – IRWD IPXL EXAM HZNP 2:00 p.m. June 19, 2014 - InvestorPlace.com
Horizon finance chief to retire 4:23 p.m. June 18, 2014 - Seeking Alpha
Hard to Find Any Negatives 4:35 p.m. June 17, 2014 - RealMoney.com
Still Churning Higher 1:29 p.m. June 17, 2014 - RealMoney.com
Bear Killers Are on the Hunt 10:22 a.m. June 17, 2014 - RealMoney.com
Hottest Healthcare Stocks Now – EW HZNP PBYI SLXP 7:30 a.m. June 17, 2014 - InvestorPlace.com
Horizon Pharma: Can It Double Again? 4:48 p.m. June 16, 2014 - Seeking Alpha
Why Horizon Pharma (HZNP) Could Be Positioned for a Surge? - Tale of the Tape 8:35 a.m. June 11, 2014 - Zacks.com
Horizon Pharma (HZNP) Stock Has Huge Short Interest: Time to Cover? - Tale of the Tape 9:42 a.m. June 2, 2014 - Zacks.com
Substance Over Style: How Niche Companies Alliqua And Horizon Are Being Overlooked 9:42 a.m. May 29, 2014 - Seeking Alpha
Horizon Pharma (HZNP): An Off-the-Radar Potential Winner - Tale of the Tape 8:57 a.m. May 29, 2014 - Zacks.com
Hottest Healthcare Stocks Now – HZNP MNKD BSX ISIS 1:45 p.m. May 28, 2014 - InvestorPlace.com
Biggest Movers in Healthcare Stocks Now – ISIS CLDX HZNP IDIX 7:45 a.m. May 27, 2014 - InvestorPlace.com
U.S. Firms Pack Up for Tax Benefits 7:36 p.m. May 11, 2014 - The Wall Street Journal Interactive Edition
The 'Inversion' Premium 7:29 p.m. May 11, 2014 - The Wall Street Journal Interactive Edition

Early Briefing on Pharma Stocks -- Research on Novartis, Akorn, Horizon Pharma, and Mallinckrodt 6:50 a.m. July 2, 2014 - PR Newswire - PRF
Market Expansion, Merger Agreements, Management Transitions, and Market Activity - Analyst Notes on Intuitive Surgical, Auxilium, Horizon Pharma, Tesaro and ArQule 6:30 a.m. July 2, 2014 - PR Newswire - PRF
Horizon Pharma Announces Execution of $300 Million Senior Secured Credit Agreement in Connection With the Proposed Acquisition of Vidara 7:01 a.m. June 19, 2014 - Marketwire
Horizon Pharma Announces Robert J. De Vaere to Retire and Names Paul W. Hoelscher Chief Financial Officer 7:01 a.m. June 18, 2014 - Marketwire
Horizon Pharma to Present at the JMP Securities Healthcare Conference 2014 3:25 p.m. June 17, 2014 - Marketwire
Consent Expiry Extensions, Collaborations, Grants, Conference Presentations, and FDA Approvals - Analyst Notes on Forest Laboratories, Intuitive Surgical, Horizon Pharma, Cubist and BDSI 6:10 a.m. June 12, 2014 - PR Newswire - PRF
Horizon Pharma Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) 4:45 p.m. June 6, 2014 - Marketwire
Top Gainers Roundup -- Research on Horizon Pharma, Celldex Therapeutics, Extreme Networks, and WidePoint 6:17 a.m. May 28, 2014 - PR Newswire - PRF
Horizon Pharma to Present at the Jefferies 2014 Global Healthcare Conference 7:31 a.m. May 27, 2014 - Marketwire
Horizon Pharma Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) 5:11 p.m. May 23, 2014 - Marketwire
Financial Results, Acquisition Agreement, and Investor Meeting - Analyst Notes on Zoetis, Horizon Pharma, Akorn, Furiex and Medicines Co. 7:20 a.m. May 16, 2014 - PR Newswire - PRF
Horizon Pharma Reports First Quarter 2014 Financial Results Exceeding Expectations and Raises 2014 Full-Year Guidance 6:31 a.m. May 9, 2014 - Marketwire
Generic Drugs Industry Announces Earnings Results, Leadership Appointments, and Conference Participation - Analyst Notes on Mylan, Zoetis, Hospira, Horizon Pharma and The Medicines Co 8:00 a.m. April 30, 2014 - PR Newswire - PRF
Horizon Pharma to Host Conference Call and Webcast to Discuss First Quarter 2014 Financial Results on May 9, 2014 7:31 a.m. April 25, 2014 - Marketwire
Horizon Pharma Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) 4:36 p.m. April 23, 2014 - Marketwire
Technical Report on Top Gainers -- Research on Centene, Prana Biotechnology, Horizon Pharma, and Scientific Games 11:34 a.m. April 23, 2014 - PR Newswire - PRF
Horizon Pharma Announces the Appointment of H. Thomas Watkins to Its Board of Directors 7:31 a.m. April 17, 2014 - Marketwire
Horizon Pharma Announces Early Termination of Hart-Scott-Rodino Waiting Period for Acquisition of Vidara Therapeutics International Ltd. 7:31 a.m. April 16, 2014 - Marketwire
Recent Acquisitions, Trial Opinions, Upcoming Earnings, Inducement Grants, and Clinical Trial Results - Analyst Notes on Actavis, The Medicines Company, Hospira, Horizon Pharma, and Galectin 8:00 a.m. April 11, 2014 - PR Newswire - PRF
Horizon Pharma Announces the U.S. Patent and Trademark Office Issued an Additional Notice of Allowance With Claims Covering RAYOS(R) (Prednisone) Delayed-Release Tablets 7:31 a.m. April 10, 2014 - Marketwire

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Aker BP's Q3 2026: Strong Earnings Fuel Optimism

Third Quarter Overview: Riding the Wave Aker BP's third quarter report is a raucous symphony of successes that have the market nodding in admiration. Marking significant strides with their offshore projects, the company seems to be in a cavalier mood as it boasts higher sales volumes and promising financials. Net production came in at 374 mboepd, dampened slightly by...

Eric Dalton: Redefining Homecare with Vision and Strategy

What's Behind Eric Dalton's Continued Recognition? Now, if you told me a healthcare leader’s named 'Visionary of the Year' twice in a row, my first thought isn't 'stretch goals' but 'show me the goods.' And that’s precisely what Eric J. Dalton has done. The Vice President at Angels on Call Homecare isn't just tooting his own horn; he's building a damn symphony in the...

Labcorp Lifts 2026 Guidance Amid Strong Q3 Performance

Labcorp's Q3 Numbers Speak Loud and Clear Another quarter, another robust set of numbers for Labcorp (NYSE:LH). The company is strutting into the spotlight with third-quarter 2026 results that have investors nodding in approval. Revenue surged to $3.81 billion, marking a 6.9% increase from the prior year's $3.56 billion. And get this: adjusted EPS jumped 14.5%, clocking...

DERMALOG Bolsters Biometric Defense with Key Wins

DERMALOG Rides High with PAD Success Germany-based DERMALOG just gave biometric crooks a run for their money. In a testament to gutsy tech work, they've hit a homerun with the latest independent security evaluations. They’ve managed to spot and shut down all 1,500 tried and tested spoofs in presentation attacks—think photos, videos, and phony fingerprints. That’s no...

ESENTIA Lifts EBITDA, Reduces Debt, Eyes Expansion

ESENTIA Flexes Financial Muscles: What's the Deal? Walk with me through the gritty world of financials, and you’ll see that ESENTIA’s latest figures are a mixed bag with a tantalizing upside. We're talking about adjusted EBITDA ticking up to a cool $86 million in the third quarter of '26, a 1.3% lift from last year. Not too shabby, eh? Especially when you're grappling...

Quad Sees Marginal Gains Amid Industry Challenges

Treading Water with a Splash of Strategic Moves When you're in the thick of market shifts, sometimes it's not about big leaps but staying afloat with purpose. That's what Quad's recent financial release seems to hint at. A steady net sales figure hovering at $587 million for Q3 2026, barely a nudge compared to last year's numbers, sets the tone. It's not the fireworks...

Arctic Wolf Leads in AI SOC: A 2026 Game Changer

Leading the Pack with AI-Powered Security In the world of cybersecurity, where every day feels like a battlefield, Arctic Wolf has clawed its way to the top spot in the Q4 2026 QKS SPARK Matrix™ for AI SOC Automation. This recognition doesn't just highlight their prowess in handling security operations; it underscores their relentless commitment to infusing AI...

AEP's $100B Power Plan: Investing in Tomorrow's Energy

Electricity Powerhouse Unleashes Ambitious Plan If you thought American Electric Power (NASDAQ:AEP) was just cruising along, think again. This week, they rolled out an eye-popping $100 billion plan to supercharge their infrastructure and meet soaring electricity demands. It’s like they’re building the future of power right in front of our eyes. Third-quarter earnings...

South Dakota's BEES Launch: Child Care Assistance Goes Live

RedMane and South Dakota DSS: A New Milestone Talk about a leap into the digital age. South Dakota's Department of Social Services, teaming up with RedMane Technology, has just rolled out the Child Care Assistance Program on their BEES platform. That’s Benefits Eligibility and Enrollment System for those not keeping track. It represents a significant step in making life...

CapCut Leads 2026 AI Image Tools for Creatives

CapCut Emerges as a Go-To in AI Imagery There's no better feeling than striking gold in a flooded market. CapCut's got folks buzzing in 2026 for its top-tier AI image creation tools, according to Expert Consumers' latest rankings. On the surface, it might just seem like another tech gimmick, but dig a bit deeper, and you'll see why it's a game changer. From adland to...